Phase 3 CodeBreaK 300 results link circulating tumor DNA clearance to efficacy and prognosis with sotorasib plus panitumumab. (JCO)
ctDNA clearance as early biomarker in KRAS G12C colorectal cancer
The CRC Digest
The CRC Digest
Phase 3 CodeBreaK 300 results link circulating tumor DNA clearance to efficacy and prognosis with sotorasib plus panitumumab. (JCO)